| Name | Pearle Vision |
|---|---|
| Organization Name | New England Vision Inc |
| Location | 739 Broadway, Saugus, Massachusetts 01906 |
| Type | Supplier |
| Phone | (781) 231-1097 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
U.S. Department of Health and Human Services today unveiled a new comprehensive tobacco control strategy that includes proposed new bolder health warnings on cigarette packages and advertisements. Once final, these health warnings on cigarettes and in cigarette advertisements will be the most significant change in more than 25 years. These actions are part of a broader strategy that will help tobacco users quit and prevent children from starting.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
The World Bank and Pfizer Inc. today announced they will collaborate to improve the healthcare infrastructure, specifically the supply chain, in developing countries, starting with Africa. The novel public-private collaboration will focus on enhanced use of Information and Communication Technologies' transformative power to improve healthcare delivery.
Seattle Children's Research Institute today announced a $5 million gift from Ben Towne Pediatric Cancer Research Foundation. The funding will be used to accelerate the work of Michael Jensen, MD, and his Seattle Children's Research Institute team who are creating new cancer treatments that reprogram a child's immune system to attack and kill cancer cells with the goal of minimizing or even eliminating the need for chemotherapy or radiation.
NPR's "Shots" blog reports on the results of a "high-visibility pilot project to vaccinate 100,000 Haitians against cholera." The blog writes, "Almost 90 percent of the target population - half in Port-au-Prince and the other half in a remote rural area - got fully protected against cholera, meaning they got two doses of the oral vaccine."
› Verified 6 days ago
News Archive
U.S. Department of Health and Human Services today unveiled a new comprehensive tobacco control strategy that includes proposed new bolder health warnings on cigarette packages and advertisements. Once final, these health warnings on cigarettes and in cigarette advertisements will be the most significant change in more than 25 years. These actions are part of a broader strategy that will help tobacco users quit and prevent children from starting.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced today that its Chairman & CEO, Dr. Daniel Chain, was granted a patent by the European Patent and Trademark Office related to the use of insulin sensitizers for the prevention and treatment of memory loss and dementia. Insulin sensitizer drugs include Rosiglitazone and Pioglitazone, which have been approved for the treatment of type II diabetes mellitus.
The World Bank and Pfizer Inc. today announced they will collaborate to improve the healthcare infrastructure, specifically the supply chain, in developing countries, starting with Africa. The novel public-private collaboration will focus on enhanced use of Information and Communication Technologies' transformative power to improve healthcare delivery.
Seattle Children's Research Institute today announced a $5 million gift from Ben Towne Pediatric Cancer Research Foundation. The funding will be used to accelerate the work of Michael Jensen, MD, and his Seattle Children's Research Institute team who are creating new cancer treatments that reprogram a child's immune system to attack and kill cancer cells with the goal of minimizing or even eliminating the need for chemotherapy or radiation.
NPR's "Shots" blog reports on the results of a "high-visibility pilot project to vaccinate 100,000 Haitians against cholera." The blog writes, "Almost 90 percent of the target population - half in Port-au-Prince and the other half in a remote rural area - got fully protected against cholera, meaning they got two doses of the oral vaccine."
› Verified 6 days ago
Cvs Pharmacy # 02500 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1075 Broadway St, Saugus, Massachusetts 01906 Phone: (781) 233-2643 | |
Cvs Pharmacy #16634 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 400 Lynn Fells Pkwy, Saugus, Massachusetts 01906 Phone: (781) 307-0001 | |
Lenscrafters #866 Type: Eyewear Supplier (Equipment, not the service) Location: 159 Square One Mall, Saugus, Massachusetts 01906 Phone: (781) 231-3776 | |
Lenscrafters At Macy's #9403 Type: Eyewear Supplier (Equipment, not the service) Location: 1185 Broadway, Saugus, Massachusetts 01906 Phone: (781) 941-8103 | |
Pearle Vision Type: Medicare Supplier Location: 739 Broadway, Saugus, Massachusetts 01906 Phone: (781) 231-1097 |